Priapismus as Leukostasis Manifestation in Chronic Myeloid Leukemia

Authors

  • Wulyo Rajabto Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Jane A.C. Djianzonie Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Livy B Pratisthita Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Hamzah Shatri Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Keywords:

priapismus, leukostasis, chronic myeloid leukemia

Abstract

Chronic Myeloid Leukemia (CML) is a myeloproliferative disease characterized by the presence of Philadelphia chromosome or BCR-ABL oncogene fusion. Patients with CML commonly present in the chronic phase with chief complaint of abdominal pain or early satiety. Priapism as the first manifestation of CML is a rare phenomenon. Priapism as a consequence of leukostasis is a urological emergency that requires immediate intracavernosus therapy followed by systemic therapy. We report a 44-year-old male patient presenting with priapism as the first manifestation of CML.

References

Jameel T, Mehmood K. Priapism – An unusual presentation in chronic myeloid leukaemia: case report and review of the literature. Biomedica. 2009;25:197–9.

Rodgers R, Latif Z, Copland M. How I manage priapism in chronic myeloid leukaemia patients. Br J Haematol. 2012;158(2):155–64.

Montague D, Jarow J, Broderick, et al. The management of erectile dysfunction: an AUA update. J Urol. 2010;174:230–9.

Gupta A, Seth T, Gupta A. Successful use of terbutaline in persistent priapism in a 12-year-old boy with chronic myeloid leukemia. Pediatr Hematol Oncol. 2009;26(1):70–3.

Hochhaus A, Kantarjian H. The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients. J Cancer Res Clin Oncol. 2013;139:1971–84.

Downloads

Published

2020-12-28

How to Cite

Rajabto, W., Djianzonie, J. A., Pratisthita, L. B., & Shatri, H. (2020). Priapismus as Leukostasis Manifestation in Chronic Myeloid Leukemia. Acta Medica Indonesiana, 52(4), 420. Retrieved from http://www.actamedindones.org/index.php/ijim/article/view/1638

Issue

Vol. 52 No. 4 (2020): Acta Medica Indonesiana

Section

MEDICAL ILLUSTRATION

License

Copyright

The authors who publish in this journal agree to the following requirements:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Similar Articles

You may also start an advanced similarity search for this article.